IL5 and schistosomiasis: In fact, the targeting of identified profibrotic cytokines (IL-5; IL-13) and growth factors (CTGF; TGF-β1 and VEGF) should be pursued in conjunction or as an alternative to current disease control measures to attempt to alleviate the fibrosis process during hepatosplenic schistosomiasis.